Page last updated: 2024-10-27

gabexate and Primary Peritonitis

gabexate has been researched along with Primary Peritonitis in 2 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research Excerpts

ExcerptRelevanceReference
"The effects of protease inhibitors(PI), t-AMCHA, gabexate, aprotinin and heparin on the growth of mouse MM2 ascites tumor (MAT) and on several components of fibrinolysis were studied."3.67[Studies on fibrinolysis and ascites accumulation associated with peritonitis carcinomatosa--effects of protease inhibitors (PI) on MM2 ascites tumor growth, ascites accumulation and fibrinolysis]. ( Shibata, J, 1986)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akahoshi, T1
Sugimori, H1
Kaku, N1
Tokuda, K1
Nagata, T1
Noda, E1
Morita, M1
Hashizume, M1
Maehara, Y1
Shibata, J1

Other Studies

2 other studies available for gabexate and Primary Peritonitis

ArticleYear
Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
    European journal of trauma and emergency surgery : official publication of the European Trauma Society, 2015, Volume: 41, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Critical Care; Disseminated Intravascular Coagulatio

2015
[Studies on fibrinolysis and ascites accumulation associated with peritonitis carcinomatosa--effects of protease inhibitors (PI) on MM2 ascites tumor growth, ascites accumulation and fibrinolysis].
    Nihon Sanka Fujinka Gakkai zasshi, 1986, Volume: 38, Issue:5

    Topics: Animals; Aprotinin; Ascites; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Fibrinolysis; Gab

1986